newsfilter
← Latest News
GlobeNewswire·

Jasper Therapeutics, Inc. Announces Results of the Offer to Purchase Relating to Its Warrants

REDWOOD CITY, Calif., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) ("Jasper" or the "Company"), a clinical stage biotechnology company focused on the design and development